Sachs Associates 13th Annual Biotech in Europe Investor Forum

| Print |
Tuesday, 08 October 2013 10:30 (UTC + 2)

Sachs Associates Logo

London, UK, October 8, 2013 / B3C newswire / - Sachs Associates 13th Annual BIEIF took place in Zurich, Switzerland on 30th September-1st October 2013 with the largest turnout in several years. Over 300 delegates and 85 presenting companies participated, and over 600 pre-arranged meetings took place on the first day alone. Delegate sentiment was very positive and points to a strong recovery following the USA earlier this year.

The Sachs Biotech in Europe Investor Forum is one of the few independent investor meetings. Since inception, the conference has been successful in attracting participants from small biotech and medtech to bellwether biotech and top tier pharma companies, as well as a great number of venture capital investors.

For future events, please refer to our website, http://www.sachsforum.com/futevents_fs.html.


About Sachs Associates
Sachs Associates organises and produces securities and emerging markets conferences in association with major exchanges and news agencies. Sachs Associates is dedicated to the highest quality standards in conferencing and, as a result, produces limited number of events each year. Sachs Associates investment conferences focus on Emerging Markets, European Equities and Technology, and are held in major financial centres such as London, New York and Zurich. The Sachs Associates conferences- stimulate the exchange of ideas and information, facilitate and accelerate business transactions.


Contact

Mina Orda
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Tel:  +44 (0)203 463 4890
Fax: +44 (0)207 691 7919
www.sachsforum.com